Stay updated on Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” terminology was removed.
    Difference
    1%
    Check dated 2026-11-07T12:23:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer identifies the site as revision v3.8.0 instead of v3.7.2; the study record still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T12:50:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    An NIH-wide notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The clinical study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T13:34:46.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:34:52.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer's site revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:35:58.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, indicating access to the study record is blocked rather than presenting the study details.
    Difference
    18%
    Check dated 2026-09-19T19:08:51.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Collecting Ducts Renal Cell Carcinoma Clinical Trial page.